58 related articles for article (PubMed ID: 21609529)
1. [Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels W822X].
Zhang JT; Huang J; Teng SY; Wang RR; Zhang YH; Pu JL; Hui RT; Zhang S
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):238-41. PubMed ID: 21609529
[TBL] [Abstract][Full Text] [Related]
2. Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels.
Teng S; Gao L; Paajanen V; Pu J; Fan Z
Cardiovasc Res; 2009 Aug; 83(3):473-80. PubMed ID: 19377070
[TBL] [Abstract][Full Text] [Related]
3. Readthrough of SCN5A Nonsense Mutations p.R1623X and p.S1812X Questions Gene-therapy in Brugada Syndrome.
Teng S; Huang J; Gao Z; Hao J; Yang Y; Zhang S; Pu J; Hui R; Wu Y; Fan Z
Curr Gene Ther; 2017; 17(1):50-58. PubMed ID: 28552050
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in the SCN5A gene is associated with Brugada syndrome.
Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK
Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278
[TBL] [Abstract][Full Text] [Related]
5. Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome.
Baroudi G; Acharfi S; Larouche C; Chahine M
Circ Res; 2002 Jan; 90(1):E11-6. PubMed ID: 11786529
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
[TBL] [Abstract][Full Text] [Related]
7. Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties.
Amin AS; Verkerk AO; Bhuiyan ZA; Wilde AA; Tan HL
Acta Physiol Scand; 2005 Dec; 185(4):291-301. PubMed ID: 16266370
[TBL] [Abstract][Full Text] [Related]
8. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
9. MOG1: a new susceptibility gene for Brugada syndrome.
Kattygnarath D; Maugenre S; Neyroud N; Balse E; Ichai C; Denjoy I; Dilanian G; Martins RP; Fressart V; Berthet M; Schott JJ; Leenhardt A; Probst V; Le Marec H; Hainque B; Coulombe A; Hatem SN; Guicheney P
Circ Cardiovasc Genet; 2011 Jun; 4(3):261-8. PubMed ID: 21447824
[TBL] [Abstract][Full Text] [Related]
10. Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A.
Kosmidis G; Veerman CC; Casini S; Verkerk AO; van de Pas S; Bellin M; Wilde AA; Mummery CL; Bezzina CR
Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784737
[TBL] [Abstract][Full Text] [Related]
11. Tetrodotoxin-resistant Na+ channels in human neuroblastoma cells are encoded by new variants of Nav1.5/SCN5A.
Ou SW; Kameyama A; Hao LY; Horiuchi M; Minobe E; Wang WY; Makita N; Kameyama M
Eur J Neurosci; 2005 Aug; 22(4):793-801. PubMed ID: 16115203
[TBL] [Abstract][Full Text] [Related]
12. Functional suppression of sodium channels by beta(1)-subunits as a molecular mechanism of idiopathic ventricular fibrillation.
Wan X; Wang Q; Kirsch GE
J Mol Cell Cardiol; 2000 Oct; 32(10):1873-84. PubMed ID: 11013131
[TBL] [Abstract][Full Text] [Related]
13. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
[TBL] [Abstract][Full Text] [Related]
14. A novel nonsense mutation in the SCN5A gene leads to Brugada syndrome and a silent gene mutation carrier state.
Keller DI; Barrane FZ; Gouas L; Martin J; Pilote S; Suarez V; Osswald S; Brink M; Guicheney P; Schwick N; Chahine M
Can J Cardiol; 2005 Sep; 21(11):925-31. PubMed ID: 16239976
[TBL] [Abstract][Full Text] [Related]
15. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome.
Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP
Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757
[TBL] [Abstract][Full Text] [Related]
16. Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channel.
Harmer SC; Mohal JS; Kemp D; Tinker A
Biochem J; 2012 May; 443(3):635-42. PubMed ID: 22309168
[TBL] [Abstract][Full Text] [Related]
17. Small interfering RNA-mediated selective knockdown of Na(V)1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic rats.
Dong XW; Goregoaker S; Engler H; Zhou X; Mark L; Crona J; Terry R; Hunter J; Priestley T
Neuroscience; 2007 May; 146(2):812-21. PubMed ID: 17367951
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of protein kinase C inhibits bursting in disease-linked mutant human cardiac sodium channels.
Tateyama M; Kurokawa J; Terrenoire C; Rivolta I; Kass RS
Circulation; 2003 Jul; 107(25):3216-22. PubMed ID: 12796143
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome.
Oginosawa Y; Nagatomo T; Abe H; Makita N; Makielski JC; Nakashima Y
Cardiovasc Res; 2005 Jan; 65(1):138-47. PubMed ID: 15621041
[TBL] [Abstract][Full Text] [Related]
20. Effect of mibefradil on sodium and calcium currents.
Strege PR; Bernard CE; Ou Y; Gibbons SJ; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G249-53. PubMed ID: 15790762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
